美国 · 通讯社与实时数据 · PR Newswire
Harbour BioMed Announces NMPA Acceptance of IND Application for Its First AI-Enabled Drug Candidate LET003 for the Treatment of Overweight or Obesity

详细摘要
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , Nov. 18, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to…
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.prnewswire.com)
